Management could support the stock with a positive update on the Vitiligo trial. They don't because...
1. There is nothing positive to report
2. They are complicit and happy with the price decline
You decide.
- Forums
- ASX - By Stock
- CUV
- Look at it this way...
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.89%
!
$10.80

Look at it this way...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.80 |
Change
0.200(1.89%) |
Mkt cap ! $541.3M |
Open | High | Low | Value | Volume |
$10.46 | $10.94 | $10.42 | $1.518M | 142.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 498 | $10.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.88 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 498 | 10.800 |
1 | 500 | 10.750 |
1 | 1000 | 10.730 |
1 | 1000 | 10.710 |
1 | 4955 | 10.680 |
Price($) | Vol. | No. |
---|---|---|
10.900 | 500 | 1 |
11.000 | 186 | 2 |
11.010 | 350 | 1 |
11.060 | 494 | 1 |
11.100 | 1000 | 1 |
Last trade - 16.10pm 15/09/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online